 | • レポートコード：MRC2-11QY04386 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は前立腺がん診断・治療のグローバル市場について調査・分析したレポートです。種類別（前立腺特異抗原検査（PSA）、直腸指診（DRE））市場規模、用途別（病院、診断クリニック、研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別前立腺がん診断・治療の競争状況、市場シェア ・世界の前立腺がん診断・治療市場：種類別市場規模 2015年-2020年（前立腺特異抗原検査（PSA）、直腸指診（DRE）） ・世界の前立腺がん診断・治療市場：種類別市場規模予測 2021年-2026年（前立腺特異抗原検査（PSA）、直腸指診（DRE）） ・世界の前立腺がん診断・治療市場：用途別市場規模 2015年-2020年（病院、診断クリニック、研究センター） ・世界の前立腺がん診断・治療市場：用途別市場規模予測 2021年-2026年（病院、診断クリニック、研究センター） ・北米の前立腺がん診断・治療市場分析：米国、カナダ ・ヨーロッパの前立腺がん診断・治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの前立腺がん診断・治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の前立腺がん診断・治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの前立腺がん診断・治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、AbbVie、Active Biotech、Amgen、Astellas Pharma、AstraZeneca、Bavarian Nordic、Bayer、Bristol-Myers Squibb、Dendreon、Endo、Ferring Pharmaceuticals、GE Healthcare、GSK、Ipsen、Johnson & Johnson、Pfizer、Sanofi、Siemens Healthineers、Takeda、Teva Pharmaceutical、Tolmar Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system.
The market is growing impressively due to rise in incidence and prevalence rate of prostate cancer, robust R&D exploration and rising investment in grants and investment across the globe.
Market Analysis and Insights: Global Prostate Cancer Diagnosis and Treatment Market
The global Prostate Cancer Diagnosis and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Prostate Cancer Diagnosis and Treatment Scope and Market Size
Prostate Cancer Diagnosis and Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Diagnosis and Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
AbbVie
Active Biotech
Amgen
Astellas Pharma
AstraZeneca
Bavarian Nordic
Bayer
Bristol-Myers Squibb
Dendreon
Endo
Ferring Pharmaceuticals
GE Healthcare
GSK
Ipsen
Johnson & Johnson
Pfizer
Sanofi
Siemens Healthineers
Takeda
Teva Pharmaceutical
Tolmar Pharmaceuticals
Market segment by Type, the product can be split into
Prostate specific antigen test (PSA)
Digital rectal exam (DRE)
Market segment by Application, split into
Hospitals
Diagnostic clinics
Research centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Prostate Cancer Diagnosis and Treatment Revenue
1.4 Market by Type
1.4.1 Global Prostate Cancer Diagnosis and Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Prostate specific antigen test (PSA)
1.4.3 Digital rectal exam (DRE)
1.5 Market by Application
1.5.1 Global Prostate Cancer Diagnosis and Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostic clinics
1.5.4 Research centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Diagnosis and Treatment Market Perspective (2015-2026)
2.2 Global Prostate Cancer Diagnosis and Treatment Growth Trends by Regions
2.2.1 Prostate Cancer Diagnosis and Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Prostate Cancer Diagnosis and Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Prostate Cancer Diagnosis and Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Prostate Cancer Diagnosis and Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Diagnosis and Treatment Players by Market Size
3.1.1 Global Top Prostate Cancer Diagnosis and Treatment Players by Revenue (2015-2020)
3.1.2 Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Prostate Cancer Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Prostate Cancer Diagnosis and Treatment Market Concentration Ratio
3.2.1 Global Prostate Cancer Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnosis and Treatment Revenue in 2019
3.3 Prostate Cancer Diagnosis and Treatment Key Players Head office and Area Served
3.4 Key Players Prostate Cancer Diagnosis and Treatment Product Solution and Service
3.5 Date of Enter into Prostate Cancer Diagnosis and Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Prostate Cancer Diagnosis and Treatment Historic Market Size by Type (2015-2020)
4.2 Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020)
5.2 Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Prostate Cancer Diagnosis and Treatment Market Size (2015-2020)
6.2 Prostate Cancer Diagnosis and Treatment Key Players in North America (2019-2020)
6.3 North America Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020)
6.4 North America Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Prostate Cancer Diagnosis and Treatment Market Size (2015-2020)
7.2 Prostate Cancer Diagnosis and Treatment Key Players in Europe (2019-2020)
7.3 Europe Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020)
7.4 Europe Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020)
8 China
8.1 China Prostate Cancer Diagnosis and Treatment Market Size (2015-2020)
8.2 Prostate Cancer Diagnosis and Treatment Key Players in China (2019-2020)
8.3 China Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020)
8.4 China Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Prostate Cancer Diagnosis and Treatment Market Size (2015-2020)
9.2 Prostate Cancer Diagnosis and Treatment Key Players in Japan (2019-2020)
9.3 Japan Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020)
9.4 Japan Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Prostate Cancer Diagnosis and Treatment Market Size (2015-2020)
10.2 Prostate Cancer Diagnosis and Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020)
11 India
11.1 India Prostate Cancer Diagnosis and Treatment Market Size (2015-2020)
11.2 Prostate Cancer Diagnosis and Treatment Key Players in India (2019-2020)
11.3 India Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020)
11.4 India Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Prostate Cancer Diagnosis and Treatment Market Size (2015-2020)
12.2 Prostate Cancer Diagnosis and Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020)
12.4 Central & South America Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Prostate Cancer Diagnosis and Treatment Introduction
13.1.4 Abbott Laboratories Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 AbbVie
13.2.1 AbbVie Company Details
13.2.2 AbbVie Business Overview
13.2.3 AbbVie Prostate Cancer Diagnosis and Treatment Introduction
13.2.4 AbbVie Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
13.2.5 AbbVie Recent Development
13.3 Active Biotech
13.3.1 Active Biotech Company Details
13.3.2 Active Biotech Business Overview
13.3.3 Active Biotech Prostate Cancer Diagnosis and Treatment Introduction
13.3.4 Active Biotech Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
13.3.5 Active Biotech Recent Development
13.4 Amgen
13.4.1 Amgen Company Details
13.4.2 Amgen Business Overview
13.4.3 Amgen Prostate Cancer Diagnosis and Treatment Introduction
13.4.4 Amgen Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
13.4.5 Amgen Recent Development
13.5 Astellas Pharma
13.5.1 Astellas Pharma Company Details
13.5.2 Astellas Pharma Business Overview
13.5.3 Astellas Pharma Prostate Cancer Diagnosis and Treatment Introduction
13.5.4 Astellas Pharma Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
13.5.5 Astellas Pharma Recent Development
13.6 AstraZeneca
13.6.1 AstraZeneca Company Details
13.6.2 AstraZeneca Business Overview
13.6.3 AstraZeneca Prostate Cancer Diagnosis and Treatment Introduction
13.6.4 AstraZeneca Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
13.6.5 AstraZeneca Recent Development
13.7 Bavarian Nordic
13.7.1 Bavarian Nordic Company Details
13.7.2 Bavarian Nordic Business Overview
13.7.3 Bavarian Nordic Prostate Cancer Diagnosis and Treatment Introduction
13.7.4 Bavarian Nordic Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
13.7.5 Bavarian Nordic Recent Development
13.8 Bayer
13.8.1 Bayer Company Details
13.8.2 Bayer Business Overview
13.8.3 Bayer Prostate Cancer Diagnosis and Treatment Introduction
13.8.4 Bayer Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
13.8.5 Bayer Recent Development
13.9 Bristol-Myers Squibb
13.9.1 Bristol-Myers Squibb Company Details
13.9.2 Bristol-Myers Squibb Business Overview
13.9.3 Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Introduction
13.9.4 Bristol-Myers Squibb Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
13.9.5 Bristol-Myers Squibb Recent Development
13.10 Dendreon
13.10.1 Dendreon Company Details
13.10.2 Dendreon Business Overview
13.10.3 Dendreon Prostate Cancer Diagnosis and Treatment Introduction
13.10.4 Dendreon Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
13.10.5 Dendreon Recent Development
13.11 Endo
10.11.1 Endo Company Details
10.11.2 Endo Business Overview
10.11.3 Endo Prostate Cancer Diagnosis and Treatment Introduction
10.11.4 Endo Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
10.11.5 Endo Recent Development
13.12 Ferring Pharmaceuticals
10.12.1 Ferring Pharmaceuticals Company Details
10.12.2 Ferring Pharmaceuticals Business Overview
10.12.3 Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Introduction
10.12.4 Ferring Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
10.12.5 Ferring Pharmaceuticals Recent Development
13.13 GE Healthcare
10.13.1 GE Healthcare Company Details
10.13.2 GE Healthcare Business Overview
10.13.3 GE Healthcare Prostate Cancer Diagnosis and Treatment Introduction
10.13.4 GE Healthcare Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
10.13.5 GE Healthcare Recent Development
13.14 GSK
10.14.1 GSK Company Details
10.14.2 GSK Business Overview
10.14.3 GSK Prostate Cancer Diagnosis and Treatment Introduction
10.14.4 GSK Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
10.14.5 GSK Recent Development
13.15 Ipsen
10.15.1 Ipsen Company Details
10.15.2 Ipsen Business Overview
10.15.3 Ipsen Prostate Cancer Diagnosis and Treatment Introduction
10.15.4 Ipsen Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
10.15.5 Ipsen Recent Development
13.16 Johnson & Johnson
10.16.1 Johnson & Johnson Company Details
10.16.2 Johnson & Johnson Business Overview
10.16.3 Johnson & Johnson Prostate Cancer Diagnosis and Treatment Introduction
10.16.4 Johnson & Johnson Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
10.16.5 Johnson & Johnson Recent Development
13.17 Pfizer
10.17.1 Pfizer Company Details
10.17.2 Pfizer Business Overview
10.17.3 Pfizer Prostate Cancer Diagnosis and Treatment Introduction
10.17.4 Pfizer Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
10.17.5 Pfizer Recent Development
13.18 Sanofi
10.18.1 Sanofi Company Details
10.18.2 Sanofi Business Overview
10.18.3 Sanofi Prostate Cancer Diagnosis and Treatment Introduction
10.18.4 Sanofi Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
10.18.5 Sanofi Recent Development
13.19 Siemens Healthineers
10.19.1 Siemens Healthineers Company Details
10.19.2 Siemens Healthineers Business Overview
10.19.3 Siemens Healthineers Prostate Cancer Diagnosis and Treatment Introduction
10.19.4 Siemens Healthineers Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
10.19.5 Siemens Healthineers Recent Development
13.20 Takeda
10.20.1 Takeda Company Details
10.20.2 Takeda Business Overview
10.20.3 Takeda Prostate Cancer Diagnosis and Treatment Introduction
10.20.4 Takeda Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
10.20.5 Takeda Recent Development
13.21 Teva Pharmaceutical
10.21.1 Teva Pharmaceutical Company Details
10.21.2 Teva Pharmaceutical Business Overview
10.21.3 Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Introduction
10.21.4 Teva Pharmaceutical Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
10.21.5 Teva Pharmaceutical Recent Development
13.22 Tolmar Pharmaceuticals
10.22.1 Tolmar Pharmaceuticals Company Details
10.22.2 Tolmar Pharmaceuticals Business Overview
10.22.3 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Introduction
10.22.4 Tolmar Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
10.22.5 Tolmar Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Prostate Cancer Diagnosis and Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Prostate Cancer Diagnosis and Treatment Revenue
Table 3. Ranking of Global Top Prostate Cancer Diagnosis and Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Prostate Cancer Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Prostate specific antigen test (PSA)
Table 6. Key Players of Digital rectal exam (DRE)
Table 7. Global Prostate Cancer Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Prostate Cancer Diagnosis and Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Prostate Cancer Diagnosis and Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Prostate Cancer Diagnosis and Treatment Market Share by Regions (2015-2020)
Table 11. Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Prostate Cancer Diagnosis and Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Prostate Cancer Diagnosis and Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Prostate Cancer Diagnosis and Treatment Players
Table 18. Global Prostate Cancer Diagnosis and Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Prostate Cancer Diagnosis and Treatment Market Share by Players (2015-2020)
Table 20. Global Top Prostate Cancer Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Diagnosis and Treatment as of 2019)
Table 21. Global Prostate Cancer Diagnosis and Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Prostate Cancer Diagnosis and Treatment Product Solution and Service
Table 24. Date of Enter into Prostate Cancer Diagnosis and Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Prostate Cancer Diagnosis and Treatment Market Size Share by Type (2015-2020)
Table 28. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Prostate Cancer Diagnosis and Treatment Market Size Share by Application (2015-2020)
Table 30. Global Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Prostate Cancer Diagnosis and Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Prostate Cancer Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Prostate Cancer Diagnosis and Treatment Market Share (2019-2020)
Table 34. North America Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Prostate Cancer Diagnosis and Treatment Market Share by Type (2015-2020)
Table 36. North America Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Prostate Cancer Diagnosis and Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Prostate Cancer Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Prostate Cancer Diagnosis and Treatment Market Share (2019-2020)
Table 40. Europe Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Prostate Cancer Diagnosis and Treatment Market Share by Type (2015-2020)
Table 42. Europe Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Prostate Cancer Diagnosis and Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Prostate Cancer Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Prostate Cancer Diagnosis and Treatment Market Share (2019-2020)
Table 46. China Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Prostate Cancer Diagnosis and Treatment Market Share by Type (2015-2020)
Table 48. China Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Prostate Cancer Diagnosis and Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Prostate Cancer Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Prostate Cancer Diagnosis and Treatment Market Share (2019-2020)
Table 52. Japan Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Prostate Cancer Diagnosis and Treatment Market Share by Type (2015-2020)
Table 54. Japan Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Prostate Cancer Diagnosis and Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Prostate Cancer Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Prostate Cancer Diagnosis and Treatment Market Share (2019-2020)
Table 58. Southeast Asia Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Prostate Cancer Diagnosis and Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Prostate Cancer Diagnosis and Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Prostate Cancer Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Prostate Cancer Diagnosis and Treatment Market Share (2019-2020)
Table 64. India Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Prostate Cancer Diagnosis and Treatment Market Share by Type (2015-2020)
Table 66. India Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Prostate Cancer Diagnosis and Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Prostate Cancer Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Prostate Cancer Diagnosis and Treatment Market Share (2019-2020)
Table 70. Central & South America Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Prostate Cancer Diagnosis and Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Prostate Cancer Diagnosis and Treatment Market Share by Application (2015-2020)
Table 74. Abbott Laboratories Company Details
Table 75. Abbott Laboratories Business Overview
Table 76. Abbott Laboratories Product
Table 77. Abbott Laboratories Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 78. Abbott Laboratories Recent Development
Table 79. AbbVie Company Details
Table 80. AbbVie Business Overview
Table 81. AbbVie Product
Table 82. AbbVie Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 83. AbbVie Recent Development
Table 84. Active Biotech Company Details
Table 85. Active Biotech Business Overview
Table 86. Active Biotech Product
Table 87. Active Biotech Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 88. Active Biotech Recent Development
Table 89. Amgen Company Details
Table 90. Amgen Business Overview
Table 91. Amgen Product
Table 92. Amgen Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 93. Amgen Recent Development
Table 94. Astellas Pharma Company Details
Table 95. Astellas Pharma Business Overview
Table 96. Astellas Pharma Product
Table 97. Astellas Pharma Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 98. Astellas Pharma Recent Development
Table 99. AstraZeneca Company Details
Table 100. AstraZeneca Business Overview
Table 101. AstraZeneca Product
Table 102. AstraZeneca Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 103. AstraZeneca Recent Development
Table 104. Bavarian Nordic Company Details
Table 105. Bavarian Nordic Business Overview
Table 106. Bavarian Nordic Product
Table 107. Bavarian Nordic Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 108. Bavarian Nordic Recent Development
Table 109. Bayer Business Overview
Table 110. Bayer Product
Table 111. Bayer Company Details
Table 112. Bayer Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 113. Bayer Recent Development
Table 114. Bristol-Myers Squibb Company Details
Table 115. Bristol-Myers Squibb Business Overview
Table 116. Bristol-Myers Squibb Product
Table 117. Bristol-Myers Squibb Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 118. Bristol-Myers Squibb Recent Development
Table 119. Dendreon Company Details
Table 120. Dendreon Business Overview
Table 121. Dendreon Product
Table 122. Dendreon Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 123. Dendreon Recent Development
Table 124. Endo Company Details
Table 125. Endo Business Overview
Table 126. Endo Product
Table 127. Endo Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 128. Endo Recent Development
Table 129. Ferring Pharmaceuticals Company Details
Table 130. Ferring Pharmaceuticals Business Overview
Table 131. Ferring Pharmaceuticals Product
Table 132. Ferring Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 133. Ferring Pharmaceuticals Recent Development
Table 134. GE Healthcare Company Details
Table 135. GE Healthcare Business Overview
Table 136. GE Healthcare Product
Table 137. GE Healthcare Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 138. GE Healthcare Recent Development
Table 139. GSK Company Details
Table 140. GSK Business Overview
Table 141. GSK Product
Table 142. GSK Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 143. GSK Recent Development
Table 144. Ipsen Company Details
Table 145. Ipsen Business Overview
Table 146. Ipsen Product
Table 147. Ipsen Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 148. Ipsen Recent Development
Table 149. Johnson & Johnson Company Details
Table 150. Johnson & Johnson Business Overview
Table 151. Johnson & Johnson Product
Table 152. Johnson & Johnson Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 153. Johnson & Johnson Recent Development
Table 154. Pfizer Company Details
Table 155. Pfizer Business Overview
Table 156. Pfizer Product
Table 157. Pfizer Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 158. Pfizer Recent Development
Table 159. Sanofi Company Details
Table 160. Sanofi Business Overview
Table 161. Sanofi Product
Table 162. Sanofi Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 163. Sanofi Recent Development
Table 164. Siemens Healthineers Company Details
Table 165. Siemens Healthineers Business Overview
Table 166. Siemens Healthineers Product
Table 167. Siemens Healthineers Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 168. Siemens Healthineers Recent Development
Table 169. Takeda Company Details
Table 170. Takeda Business Overview
Table 171. Takeda Product
Table 172. Takeda Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 173. Takeda Recent Development
Table 174. Teva Pharmaceutical Company Details
Table 175. Teva Pharmaceutical Business Overview
Table 176. Teva Pharmaceutical Product
Table 177. Teva Pharmaceutical Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 178. Teva Pharmaceutical Recent Development
Table 179. Tolmar Pharmaceuticals Company Details
Table 180. Tolmar Pharmaceuticals Business Overview
Table 181. Tolmar Pharmaceuticals Product
Table 182. Tolmar Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 183. Tolmar Pharmaceuticals Recent Development
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Diagnosis and Treatment Market Share by Type: 2020 VS 2026
Figure 2. Prostate specific antigen test (PSA) Features
Figure 3. Digital rectal exam (DRE) Features
Figure 4. Global Prostate Cancer Diagnosis and Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Diagnostic clinics Case Studies
Figure 7. Research centers Case Studies
Figure 8. Prostate Cancer Diagnosis and Treatment Report Years Considered
Figure 9. Global Prostate Cancer Diagnosis and Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Prostate Cancer Diagnosis and Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Prostate Cancer Diagnosis and Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Prostate Cancer Diagnosis and Treatment Market Share by Players in 2019
Figure 14. Global Top Prostate Cancer Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Diagnosis and Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnosis and Treatment Revenue in 2019
Figure 16. North America Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
前立腺がん治療の世界市場（～2026年） Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race. Market Analysis and Insights: Global Prostate Cancer Treatment Market The global Prostate Cancer Treatment market size is projected to reach US$ XX m…- 去勢抵抗性前立腺がん治療の世界市場（～2026年） Prostate cancer can be defined as it is a form of cancer that develops into male reproductive system. Most of the prostate cancer are slow growing and stable but sometimes it can spread from prostate (gland) to other part of body such as bone and lymph node. Initially prostate cancer does not pose a…
- 前立腺がんスクリーニングの世界市場（～2026年） Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms. The digital rectal examination is one screening tool during which the prostate is assessed manually through the wall of the rectum. The second screening tool is the measu…
- ホルモン抵抗性前立腺がんの世界市場（～2026年） Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …
- 前立腺がんの世界市場（～2026年） Prostate cancer is cancer that occurs in the prostate. Market Analysis and Insights: Global Prostate Cancer Market The global Prostate Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prostate Cancer Scope and Ma…